Reduction in hormone replacement therapy use and declining breast cancer incidence in the Belgian province of Limburg

Breast Cancer Research and Treatment

Volumn 118, Issue 2, 2009, Pages 425-432

  Vankrunkelsven, Patrik ^a   Kellen, Eliane ^a   Lousbergh, Daniël ^b   Cloes, Edith ^b   Op De Beeck, Lode ^c   Faes, Christel ^b   Bruckers, Liesbeth ^b   Mertens, Raf ^d   Coebergh, Jan W ^e   Van Leeuwen, Flora E ^f   Buntinx, Frank ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b HASSELT UNIVERSITY   (Belgium)

^c Department of Pathology   (Belgium)

^d Intermutalistisch Agentschap   (Belgium)

^e ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^f NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Breast cancer; Epidemiology; Hormonal therapy; Time trends

Indexed keywords

ADULT; AGED; ARTICLE; BELGIUM; BREAST CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER REGISTRY; CONTROLLED STUDY; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; POPULATION; PRIORITY JOURNAL; SOCIAL SECURITY;

ADULT; AGE DISTRIBUTION; AGED; BELGIUM; BREAST NEOPLASMS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; REGISTRIES;

EID: 70350212575     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-009-0346-9     Document Type: Article

References (36)

1. HE Karim-Kos E de Vries I Soerjomataram V Lemmens S Siesling JW Coebergh 2008 Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s Eur J Cancer 44 10 1345 1389 10.1016/j.ejca.2007.12.015 10.1016/j.ejca.2007.12.015 18280139
2. C Héry J Ferlay M Boniol P Autier 2008 Changes in breast cancer incidence and mortality in middle-aged and elderly women in 28 countries with Caucasian majority populations Ann Oncol 19 5 1009 1018 10.1093/annonc/mdm593 10.1093/annonc/mdm593 18296422 (Pubitemid 351627322)
3. J Ferlay P Autier M Boniol M Heanue M Colombet P Boyle 2007 Estimates of the cancer incidence and mortality in Europe in 2006 Ann Oncol 18 3 581 592 10.1093/annonc/mdl498 10.1093/annonc/mdl498 1:STN:280:DC%2BD2s7hslSgtw%3D%3D 17287242 (Pubitemid 46359643)
4. TJ Key PK Verkasalo E Banks 2001 Epidemiology of breast cancer Lancet Oncol 2 3 133 140 10.1016/S1470-2045(00)00254-0 10.1016/S1470-2045(00)00254-0 1:STN:280:DC%2BD387ntFelsw%3D%3D 11902563 (Pubitemid 33585924)
5. World Cancer Research Fund/American Institute for Cancer Research (2007) Food, nutrition, physical activity, and the prevention of cancer: a global perspective. AICR, Washington DC
6. Collaborative Group on Hormonal Factors in Breast Cancer 1997 Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer Lancet 350 9084 1047 1059 10.1016/S0140-6736(97)08233-0 10.1016/S0140-6736(97)08233-0 (Pubitemid 27437855)
7. JE Rossouw GL Anderson RL Prentice AZ LaCroix C Kooperberg ML Stefanick, et al. 2002 Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial JAMA 288 3 321 333 10.1001/jama.288.3.321 10.1001/jama.288.3.321 1:CAS:528:DC%2BD38Xltlegs7k%3D 12117397
8. SR Majumdar EA Almasi RS Stafford 2004 Promotion and prescribing of hormone therapy after report of harm by the Women's Health Initiative JAMA 292 16 1983 1988 10.1001/jama.292.16.1983 10.1001/jama.292.16.1983 1:CAS:528:DC%2BD2cXptVeksb8%3D 15507584 (Pubitemid 39411207)
9. V Beral 2003 Breast cancer and hormone-replacement therapy in the Million Women Study Lancet 362 9382 419 427 10.1016/S0140-6736(03)14065-2 10.1016/S0140-6736(03)14065-2 1:CAS:528:DC%2BD3sXmt1ajsrw%3D 12927427 (Pubitemid 36999703)
10. PM Ravdin KA Cronin N Howlader CD Berg RT Chlebowski EJ Feuer, et al. 2007 The decrease in breast-cancer incidence in 2003 in the United States N Engl J Med 356 16 1670 1674 10.1056/NEJMsr070105 10.1056/NEJMsr070105 1:CAS:528:DC%2BD2sXksFCltL0%3D 17442911 (Pubitemid 46631679)
11. V Lundberg H Tolonen B Stegmayr K Kuulasmaa K Asplund 2004 Use of oral contraceptives and hormone replacement therapy in the WHO MONICA project Maturitas 48 1 39 49 10.1016/j.maturitas.2003.08.006 10.1016/j.maturitas.2003. 08.006 1:CAS:528:DC%2BD2cXlt1Wht7c%3D 15223107 (Pubitemid 38829105)
12. I Soerjomataram JW Coebergh MW Louwman O Visser FE van Leeuwen 2007 Does the decrease in hormone replacement therapy also affect breast cancer risk in the Netherlands? J Clin Oncol 25 31 5038 5039 10.1200/JCO.2007.13.7281 10.1200/JCO.2007.13.7281 17971608 (Pubitemid 350220443)
13. National Institute for Statistics Bevolkingsdata (2008) http://ecodata.mineco.fgov.be/. Ministry of Economics, Vooruitgangsstraat 50, Brussel
14. Lousbergh D, Cloes E, Op De Beeck L, Rummens JL, Vandenbrande J, Faes C, Bruckers L, Molenberghs G, Dhollander D, Kellen E, Hensen K, Lathouwers D, Meekers E, Buntinx F (2007) Ten years of cancer in the Belgian Province of Limburg: 1996-2005. LIKAR, Hasselt
15. IMS Health Belgium, Rue de Crayer 6, 1000 Brussels (2008) Drug sales in Belgium per three months
16. P Albertazzi R Di Micco E Zanardi 1998 Tibolone: a review Maturitas 30 3 295 305 10.1016/S0378-5122(98)00059-0 10.1016/S0378-5122(98)00059-0 1:CAS:528:DyaK1MXksVymtg%3D%3D 9881330 (Pubitemid 28526436)
17. dos Santos Silva I (1999) Cancer epidemiology: principles and methods. IARC, Lyon
18. A Katalinic R Rawal 2008 Decline in breast cancer incidence after decrease in utilisation of hormone replacement therapy Breast Cancer Res Treat 107 3 427 430 10.1007/s10549-007-9566-z 10.1007/s10549-007-9566-z 1:CAS:528:DC%2BD1cXht1Sgtrg%3D 17453336 (Pubitemid 351172118)
19. HM Verkooijen VC Koot G Fioretta M van der Heiden ME Schipper E Rapiti, et al. 2008 Hormone replacement therapy, mammography screening and changing age-specific incidence rates of breast cancer: an ecological study comparing two European populations Breast Cancer Res Treat 107 3 389 395 10.1007/s10549-007- 9554-3 10.1007/s10549-007-9554-3 1:STN:280:DC%2BD1c%2FntF2msw%3D%3D 17431760 (Pubitemid 351172106)
20. FJ Van Duijnhoven CH van Gils ID Bezemer PH Peeters YT van der Schouw DE Grobbee 2006 Use of hormones in the menopausal transition period in the Netherlands between 1993 and 1997 Maturitas 53 4 462 475 10.1016/j.maturitas. 2005.08.002 10.1016/j.maturitas.2005.08.002 16198516 (Pubitemid 43319385)
21. PH Zahl J Maehlen 2007 A decline in breast-cancer incidence N Engl J Med 357 5 510 511 1:CAS:528:DC%2BD2sXos1Glsr8%3D 17674462
22. JL Botha F Bray R Sankila DM Parkin 2003 Breast cancer incidence and mortality trends in 16 European countries Eur J Cancer 39 12 1718 1729 10.1016/S0959-8049(03)00118-7 1:STN:280:DC%2BD3szlsFCnug%3D%3D 12888367 (Pubitemid 36897609)
23. A Jemal E Ward MJ Thun 2007 Recent trends in breast cancer incidence rates by age and tumor characteristics among US women Breast Cancer Res 9 3 R28 10.1186/bcr1672 10.1186/bcr1672 17477859 (Pubitemid 350214681)
24. VRIND Statistisch Jaarrapporten Vlaamse regering (1998-2000) http://aps.vlaanderen.be/statistiek/publicaties/stat-Publicaties-vrind.htm
25. Intermutualistisch Agentschap. Programma borstkankerscreening (2008) Periodes van 2002-2003 en 2004-2005. www.nic-ima.be
26. M Kumle 2008 Declining breast cancer incidence and decreased HRT use Lancet 372 9639 608 610 10.1016/S0140-6736(08)61255-6 10.1016/S0140-6736(08) 61255-6 18722851
27. HD Nelson LL Humphrey P Nygren SM Teutsch JD Allan 2002 Postmenopausal hormone replacement therapy: scientific review JAMA 288 7 872 881 10.1001/jama.288.7.872 10.1001/jama.288.7.872 1:CAS:528:DC%2BD38Xmt1yitL8%3D 12186605
28. K Kerlikowske DL Miglioretti DS Buist R Walker PA Carney 2007 Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population J Natl Cancer Inst 99 17 1335 1339 10.1093/jnci/djm111 10.1093/jnci/djm111 17698950 (Pubitemid 47394172)
29. GK Reeves V Beral J Green T Gathani D Bull 2006 Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis Lancet Oncol 7 11 910 918 10.1016/S1470-2045(06)70911-1 10.1016/S1470-2045(06)70911-1 1:CAS:528:DC%2BD28XhtFKmt7bN 17081916 (Pubitemid 44615945)
30. CI Li JR Daling 2007 Changes in breast cancer incidence rates in the United States by histologic subtype and race/ethnicity, 1995 to 2004 Cancer Epidemiol Biomarkers Prev 16 12 2773 2780 10.1158/1055-9965.EPI-07-0546 10.1158/1055-9965.EPI-07-0546 18086787 (Pubitemid 351196336)
31. Centers for Disease Control and Prevention 2007 Decline in breast cancer incidence-United States 1999-2003 MMWR 56 549 553
32. K Kerlikowske DL Miglioretti R Ballard-Barbash DL Weaver DS Buist WE Barlow, et al. 2003 Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population J Clin Oncol 21 23 4314 4321 10.1200/JCO.2003.05.151 10.1200/JCO.2003.05.151 1:CAS:528: DC%2BD2cXpsVWqu7g%3D 14645420 (Pubitemid 46621806)
33. M Garcia-Closas ME Sherman LA Brinton 2006 Clarifying breast cancer risks associated with menopausal hormone therapy Lancet Oncol 7 11 885 886 10.1016/S1470-2045(06)70915-9 10.1016/S1470-2045(06)70915-9 17081912 (Pubitemid 44615949)
34. M Dietel MA Lewis S Shapiro 2005 Hormone replacement therapy: pathobiological aspects of hormone-sensitive cancers in women relevant to epidemiological studies on HRT: a mini-review Hum Reprod 20 8 2052 2060 10.1093/humrep/dei043 10.1093/humrep/dei043 1:CAS:528:DC%2BD2MXmt1Gnu7k%3D 15932918 (Pubitemid 41418488)
35. R Prasad GP Boland A Cramer E Anderson WF Knox NJ Bundred 2003 Short-term biologic response to withdrawal of hormone replacement therapy in patients with invasive breast carcinoma Cancer 98 12 2539 2546 10.1002/cncr.11836 10.1002/cncr.11836 1:CAS:528:DC%2BD2cXit1yhsw%3D%3D 14669271 (Pubitemid 37509515)
36. Early Breast Cancer Trialist's Collaborative Group (EBCTCG) 2005 Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials Lancet 365 9472 1687 1717 10.1016/S0140-6736(05)66544-0 10.1016/S0140-6736(05)66544-0 (Pubitemid 40719106)